Carcinoma, Bronchogenic  >>  evofosfamide (IMGS-101)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
NCT00743379: Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors

Checkmark Data
Apr 2012 - Apr 2012: Data
Completed
1/2
71
US
TH-302
Threshold Pharmaceuticals
Non-Small Cell Lung Cancer, Prostate Cancer, Pancreatic Cancer
07/13
03/14

Download Options